Figures
Abstract
Cellular senescence is post-mitotic or oncogene-induced events combined with nuclear remodeling. MCAF1 (also known as hAM or ATF7IP), a transcriptional cofactor that is overexpressed in various cancers, functions in gene activation or repression, depending on interacting partners. In this study, we found that MCAF1 localizes to PML nuclear bodies in human fibroblasts and non-cancerous cells. Interestingly, depletion of MCAF1 in fibroblasts induced premature senescence that was characterized by cell cycle arrest, SA-β-gal activity, and senescence-associated heterochromatic foci (SAHF) formation. Under this condition, core histones and the linker histone H1 significantly decreased at both mRNA and protein levels, resulting in reduced nucleosome formation. Consistently, in activated Ras-induced senescent fibroblasts, the accumulation of MCAF1 in PML bodies was enhanced via the binding of this protein to SUMO molecules, suggesting that sequestration of MCAF1 to PML bodies promotes cellular senescence. Collectively, these results reveal that MCAF1 is an essential regulator of cellular senescence.
Citation: Sasai N, Saitoh N, Saitoh H, Nakao M (2013) The Transcriptional Cofactor MCAF1/ATF7IP Is Involved in Histone Gene Expression and Cellular Senescence. PLoS ONE 8(7): e68478. https://doi.org/10.1371/journal.pone.0068478
Editor: Joao P.B. Viola, National Cancer Institute (INCA), Brazil
Received: March 23, 2013; Accepted: May 31, 2013; Published: July 30, 2013
Copyright: © 2013 Sasai et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Japan Science and Technology Agency (CREST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Cellular senescence is a permanent cell cycle arrest that is induced by various stresses such as activated oncogenes, short telomeres, oxidative stress, and inadequate growth conditions [1]. In vivo evidence revealed that cellular senescence occurs in benign or premalignant lesions and acts as an important anti-tumor mechanism [2,3]. Senescent cells are characterized by several features including permanent cell cycle arrest, senescence-associated β-galactosidase (SA-β-gal) activity, morphological changes, activation of DNA damage signaling, and expression of cytokines or secreted factors [1]. Dynamic chromatin changes, including the formation of senescence-associated heterochromatin foci (SAHF), are also observed in senescent cells. The condensed chromatin in senescent cells contributes to the stable repression of proliferation-promoting genes [4]. Increasing number of proteins have been reported to be involved in the chromatin changes during the senescence process [5]. However, little is known about how the epigenetic factors are involved in and contribute to the senescence pathway.
MCAF1 (also known as hAM or ATF7IP) is a transcriptional cofactor that was originally identified as a binding protein of the transcription factor ATF7 [6]. In addition, MCAF1 associates with general transcription factors [6], RNA polymerase II [6,7], and a transcriptional activator SP1 [8]. While MCAF1 associates with the transcriptional apparatus, it also interacts with a methyl-CpG binding protein MBD1 and a H3K9 methyltransferase SETDB1 to form heterochromatin [9,10], suggesting that MCAF1 may function as both a transcriptional activator and a repressor depending on the situation. Biochemical analysis revealed that MCAF1 is an enzymatic cofactor of SETDB1. SETDB1 itself has ability to mono- and di-methylates H3K9, but in the presence of MCAF1 it can also tri-methylate H3K9 [9]. In the cancer cell line C33a, MCAF1, MBD1, and SETDB1 co-localize at the H3K9me3-containing heterochromatin region [8,11]. MCAF1 contains the SUMO-interacting motif (SIM) which preferentially binds to SUMO2/3 [12]. Modification of MBD1 with SUMO2/3 is considered to be required for the recruitment of the MCAF1/SETDB1 complex to DNA-methylated loci to form heterochromatin [11]. Although MCAF1 is overexpressed in various types of cancers [7], the biological significance of MCAF1 remains largely unknown.
Here, we find that, in the human primary diploid fibroblasts IMR90, MCAF1 localizes to PML bodies, but not to H3K9me3-containing heterochromatin. We demonstrate that siRNA-mediated knockdown of MCAF1 in IMR90 cells induces premature senescence. MCAF1 knockdown activates the expression of the cdk inhibitors p16 and p21, dephosphorylates RB, and represses a subset of cell cycle genes. Moreover, core histones and the linker histone H1 are downregulated at both mRNA and protein levels in MCAF1-depleted cells. During senescence induction by activated Ras, the MCAF1 protein level is constant. However, MCAF1 further accumulates in PML bodies in senescent cells by binding to SUMO2/3 through the SIM, implying that sequestration of MCAF1 to PML bodies is necessary for the cells to enter the senescent state. Taken together, these data suggest that MCAF1 is an important regulator of cellular senescence whose activity may be regulated by SUMO.
Material and Methods
Cell culture
IMR90 cells were purchased from ATCC (catalog no. CCL-186) and cultured in DMEM supplemented with 10% FBS. For senescence induction, IMR90 ER: Ras cells [13] were treated with 100 nM 4-hydryoxytamoxifen (4-OHT) for 6 days.
Plasmids, siRNAs, and transfection
The cDNA for wild type and D968A mutant of MCAF1 were inserted into the episomal vector pEBMulti (Wako) together with monomeric EGFP. Plasmid DNAs were transfected with Fugene HD (Roche) for 48 hr.
siRNAs used are Flexitube siRNA (SI04249455 for MCAF1-1, Qiagen), and SMART pool ON-TARGET plus (J-019289-05, J-019289-06, J-019289-07, J-019289-08 for MCAF1-2, Thermoscientific). The siRNA targeted to luciferase (GL3) was used as a control [7]. The siRNAs (2.5 nM) were transfected with the RNAiMAX transfection reagent (Life technologies) every 3 days.
SA-β-gal assay and EdU incorporation assay
SA-β-gal assay was performed using the Senescence Detection Kit (BioVision). For EdU incorporation assay, Click-iT EdU Alexa Fluor 488 Imaging kit was used (Life technologies). EdU incorporation was carried out for 1 hr at 37oC at a final concentration of 10 µM EdU.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde in PBS for 10 min at room temperature and permeabilized with 0.2% triton X-100 in PBS for 5 min on ice. After blocking with 0.5% BSA in PBS for 30 min at R.T, the cells were sequentially incubated with a primary antibody followed by an appropriate secondary antibody. DNA was stained with DAPI and the cells were mounted under coverslips. The cells were analyzed using an Olympus IX71 microscope and the Lumina Vision software. Primary antibodies used are anti-MCAF1 [10], anti-PML (PG-M3, Santa cruz), anti-SUMO2/3 (3H2) [11], anti-macroH2A (39594, Active motif), anti-GFP (A11122, Life technologies), and anti-H3K9me3 (2F3) [14].
RT-qPCR
Total RNA was extracted from cells with TRIzol reagent (Life technologies). RT reaction was carried out with the ReverTraAce qPCR RT kit (Toyobo). For analyzing histone gene expression, total RNA was treated with DNase I (Takara bio) before the RT reaction. qPCR analysis was performed using Thunderbird SYBR qPCR mix (Toyobo) and an ABI Prism 7500 system. Each experiment was carried out at least three times. The fold relative enrichment was quantified, together with normalization by the GAPDH level. Primer sequences used in this study are listed in Supplemental Table S1.
Western blot analysis
Total cell lysate was prepared by directly suspending the cells in SDS sample buffer containing benzonase (Sigma). Antibodies used are anti-MCAF1 [10], anti-β-tubulin (T4026, Sigma), anti-p16 (JC8, Santa cruz), anti-p21 (C-19, Sancta cruz), anti-RB (554136, BD), anti-H1 (61202, Active motif), anti-H3 (ab1791, abcam), anti-H2A (39592, Active motif), anti-macroH2A (39594, Active motif), anti-HRas (F235, Santa cruz), and anti-GFP (A11122, Life technologies). Quantification of bands was done with the ImageQuant TL software (GE Healthcare). The band intensities were shown relative to the control, which was normalized to 1.
MNase digestion assay
Extracted nuclei were suspended in MNase buffer (50 mM Tris-HCl pH 7.4, 320 mM sucrose, 4 mM MgCl2, and 1 mM CaCl2) and incubated with MNase (Takara bio) for the indicated times. The reaction was stopped with 10 mM EGTA. Extracted DNA was analyzed by agarose gel electrophoresis.
Microarray and gene set enrichment analysis (GSEA)
Gene expression microarray of total RNA from control or MCAF1-1 siRNA treated cells was performed by Dragon Genomics Center using an Affymetrix GeneChip Human Genome U133 Plus 2.0 array. GSEA was carried out as described [15].
Results
MCAF1 localizes to PML bodies in human normal cell lines
To gain insight into the function of MCAF1, we analyzed subcellular localization of MCAF1 in various human cell lines. Immunofluorescence analysis with anti-MCAF1 antibody revealed that MCAF1 displayed two different localization patterns depending on the cell types; heterochromatin and discrete subnuclear foci. As was the case in cancerous C33a cells [11], MCAF1 colocalized with a heterochromatin marker H3K9me3 in HeLa and MCF7 cells (Figure S1A). In contrast, in human normal fibroblasts IMR90 and primary mammary epithelial cells HMEC, MCAF1 formed 10-20 discrete nuclear foci that do not accumulate H3K9me3 (Figure 1A). Co-immunostaining analysis identified these foci as PML nuclear bodies (Figure 1B and Figure S1B). MCAF1 and PML colocalization was not observed in HeLa cells (Figure S1B). PML bodies include various proteins involved in transcription, DNA repair, and cellular senescence, and SUMOylation is considered to be essential for the assembly of PML nuclear bodies [16]. MCAF1 does not seem to be a structural component of PML bodies, since MCAF1 knockdown did not affect PML body formation (Figure S1C).
(A) Immunofluorescence analysis of endogenous MCAF1 and H3K9me3 in IMR90 cells. DNA was stained with DAPI. Scale bar: 10 µM. (B) Immunofluorescence of endogenous MCAF1 and PML in IMR90 cells. Scale bar: 10 µM.
MCAF1 knockdown induces cell cycle arrest
To examine the function of MCAF1 in PML bodies, we treated IMR90 cells with two independent siRNAs specific for MCAF1. Knockdown of MCAF1 protein was confirmed at 48 hr after siRNA treatment by Western blot analysis (Figure 2A). MCAF1 knockdown severely impaired cell proliferation (Figure 2B) and reduced incorporation of a thymidine analog EdU (Figure 2C). As MCAF1 is a transcriptional regulator, we sought to identify target genes of MCAF1 by microarray analysis. IMR90 cells were treated with control or MCAF1 siRNAs for 48 hr, total RNA was extracted, and gene expression patterns were compared between control and MCAF1 knockdown cells by microarray and the gene set enrichment analysis. The results show that cell cycle genes were significantly downregulated in MCAF1 knockdown cells (Figure S2). To independently confirm the results, we performed RT-qPCR analysis. Again, the cell cycle genes, such as E2F1, MCMs, and CDK1, were significantly decreased by both siRNAs for MCAF1 (Figure 2D), indicating that a subset of cell cycle genes are downstream targets of MCAF1 in IMR90 cells.
(A) IMR90 cells were treated with the indicated siRNAs for 48 hr and analyzed by Western blotting with anti-MCAF1 and anti-β-tubulin antibodies. The images were quantitatively assessed by densitometry. (B) Growth curves for siControl, siMCAF1-1, and siMCAF1-2 cells. (C) EdU incorporation assay in control and MCAF1 knockdown cells. **P<0.01. (D) RT-qPCR analysis of the cell cycle genes at 48 hr after siRNA treatment. **P<0.01.
Knockdown of MCAF1 induces premature senescence
We also found that the cdk inhibitors p16 and p21 were upregulated at both mRNA and protein levels (Figure 3A and S3), and RB protein was dephosphorylated in MCAF1 knockdown cells (Figure 3A). As cdk inhibitors play important roles in cellular senescence [17], we investigated if MCAF1 knockdown induced premature senescence. As shown in Figure 3B, MCAF1 knockdown cells were positive for SA-β-gal activity. To further confirm that MCAF1 depletion induced senescence, we tested the formation of SAHF in MCAF1 knockdown cells. DAPI staining showed that approximately 30% of MCAF1 knockdown cells displayed nuclear foci that resemble SAHF (Figure 3C). SAHF are facultative heterochromatin that is enriched for heterochromatin markers such as H3K9me3, HP1, and macroH2A [5]. The SAHF-like structure in MCAF1 knockdown cells were positive for macroH2A (Figure 3D) and H3K9me3 (Figure S4), indicating that MCAF1 depletion induced SAHF formation. Collectively, these results indicate that MCAF1 knockdown activates the Rb pathway to trigger premature senescence.
(A) Western blot analysis of the cdk inhibitors p16 and p21 and RB proteins in control and MCAF1 knockdown IMR90 cells. The images were quantitatively assessed by densitometry. (B, C) IMR90 cells were treated with the indicated siRNAs, and analyzed for SA-β-gal activity (B) or the formation of SAHF (C) at 8 days after siRNA treatment. **P<0.01. (D) Immunofluorescence analysis of MCAF1 and MacroH2A in control and SAHF-positive MCAF1 knockdown cells. DNA was stained with DAPI. Scale bar: 10 µM.
Reduction of histone gene expression in MCAF1 knockdown cells
We further investigated the mechanism by which MCAF1 knockdown induces premature senescence. As MCAF1 regulates chromatin state by associating with various proteins, we tested whether chromatin structure is affected in MCAF1 knockdown cells by micrococcal nuclease (MNase) digestion assay. Cell nuclei were collected from control and MCAF1 knockdown cells at 4 days after siRNA treatment. After the nuclei were treated with MNase, DNA was extracted and analyzed by agarose gel electrophoresis. As shown in Figure 4A, in control cells, MNase digestion generated nucleosome ladders (Figure 4A, left). Interestingly, in MCAF1 knockdown cells, MNase digestion produced fewer nucleosomes compared to control cells (Figure 4A, right). As the reduction of undigested DNA in MCAF1 knockdown cells was comparable to that in control cells, these results suggest that the amount of nucleosomes is reduced in MCAF1 knockdown cells.
(A) Nuclei from control and MCAF1 knockdown IMR90 cells at 4 days after siRNA treatment were digested with MNase for the indicated times and analyzed by agarose gel electrophoresis. (B) Triton-insoluble fraction at 8 day after siRNA treatment was analyzed by SDS-page followed by CBB staining. (C) Western blot analysis of total cell lysates from the indicated cells at 8 days after siRNA treatment. The images were quantitatively assessed by densitometry.
We then tested the levels of histone proteins in MCAF1 knockdown cells at 8 days after siRNA treatment. The CBB staining after SDS-PAGE showed that the levels of core histone proteins in MCAF1-depleted cells were decreased compared to control cells (Figure 4B). Western blot analysis also showed that the amount of the core histones H2A and H3 and the linker histone H1 were significantly diminished in MCAF1 knockdown cells (Figure 4C). However, the variant histone macroH2A was slightly increased in MCAF1 knockdown cells (Figure 4C), which is consistent with the fact that macroH2A is upregulated in senescent cells [18]. To next investigate whether histone genes are downregulated at a transcriptional level, using RT-qPCR analysis, we analyzed the expression of total 9 histone genes from the histone gene cluster on chromosome 1 (Figure S5A). The expression of 8 out of 9 histone genes was downregulated in MCAF1-depleted cells at 48 hr after siRNA treatment. The expression of the variant histone genes macroH2A and H3.3A, which are not located on the histone gene cluster, were not decreased by MCAF1 knockdown (Figure S5B). These results suggest that histone genes in the histone gene cluster are simultaneously regulated by MCAF1.
MCAF1 localizes to PML bodies through binding to SUMO2/3
As MCAF1 depletion induces premature senescence, we then addressed whether MCAF1 protein level decreases during the senescence process. We induced senescence by expression of 4-OHT-inducible activated Ras (H-RasV12) [13]. Western blot analysis showed that the total amount of MCAF1 protein was constant until day 6 after 4-OHT treatment when cells became fully senescent (Figure 5A). However, immunofluorescence analysis showed that MCAF1 was further accumulated in PML bodies in SAHF-positive senescent cells compared to in control cells (Figure 5B and quantitatively shown in Figure S6). Similarly, MCAF1 accumulated to PML bodies in replicatively senescent cells (Figure S7), suggesting that accumulation of MCAF1 in PML body is a general feature of senescent cells.
(A) Western blot analysis of total cell lysates at the indicated times after ER: Ras induction. (B) Immunofluorescence analysis of MCAF1 and PML at 0 and 6 days after ER: Ras induction. Scale bar: 10 µM. (C) Immunofluorescence analysis of WT and D968 mutant of MCAF1 with anti-GFP antibody in IMR90 cells. Scale bar: 10 µM. (D) Role of MCAF1 in cellular senescence. In growing cells, MCAF1 maintains cell proliferation by activating transcription of cell cycle and histone genes (left). MCAF1 knockdown downregulates cell cycle and histone genes, and results in premature senescence (middle). In oncogene-induced senescent (OIS) cells, MCAF1 is recruited to PML bodies through binding to SUMO2/3. This may inhibit MCAF1 function to maintain expression of cell cycle genes and histones (right).
We then investigated the mechanism by which MCAF1 is recruited to PML bodies. SUMO2/3 are also known to be accumulated in PML bodies in senescent cells (Figure S8A) [19]. As MCAF1 interacts with SUMO2/3 through the SIM [11], it was supposed that MCAF1 is recruited to PML bodies through binding to SUMO2/3. To address this possibility, we expressed EGFP-tagged wild type and the SIM mutant (D968A) [11] of MCAF1 in IMR90 cells and analyzed their localization by immunofluorescence analysis with anti-GFP antibody (Figure S8B). The wild type MCAF1 clearly colocalized with PML in transfected cells. In contrast, the SIM mutant of MCAF1 showed diffuse nuclear distribution, although very weak localization in PML bodies was observed (Figure 5C). These results suggest that the SUMO2/3 binding through the SIM is required for the PML body localization of MCAF1 in senescent cells.
Discussion
In this report, we demonstrated that MCAF1 is involved in the regulation of cellular senescence in human primary fibroblast cells. Our data suggest that two factors are major causative for the senescent phenotypes in MCAF1 knockdown cells; the upregulation of the cdk inhibitors and the downregulation of the histone proteins. The cdk inhibitors p16 and p21, which are upregulated in MCAF1 knockdown cells, play important roles in cellular senescence by dephosphorylating RB to repress expression of cell cycle genes [1]. Overexpression of p16 or p21 has been shown to be sufficient to induce senescent phenotypes in fibroblasts [17]. Therefore, upregulation of these cdk inhibitors may be a major factor that triggered senescence in MCAF1 knockdown cells. Further study would be necessary to elucidate which upstream factors activate p16 and p21 in MCAF1 knockdown cells.
Histone protein levels are also associated with the senescence pathway. Core histones and the liker histone H1 are known to be decreased in senescent human cells [18,20,21]. However, it remains unclear whether the histone reduction in MCAF1 knockdown cells is a cause or a result of senescence. It has been reported that histone reduction in yeast shortened lifespan [22]. In addition, depletion of the specific histone H1 variant in cancer cells results in cell cycle arrest [23]. Furthermore, knockdown of the histone variants H2AZ or CENPA induces premature senescence [24,25]. Therefore, these findings suggest that histone reduction in MCAF1 knockdown cells may also be causative for the senescence phenotypes.
MCAF1 is a transcriptional cofactor that associates with various proteins involved in transcriptional regulation. However, very few target genes of MCAF1 has been identified so far. We have reported that MCAF1 is required for cancer cell proliferation by activating the transcription of the telomerase genes, TERT and TERC [7]. ChIP-seq analysis in melanoma cells identified the HoxA gene cluster as direct MCAF1 targets [26]. The ChIP-seq data also shows the enrichment of MCAF1 at the histone gene loci and a subset of cell cycle genes, which we showed as possible downstream targets of MCAF1. Therefore, it would be likely that the cell cycle and histone genes are direct transcriptional targets of MCAF1 that are necessary to maintain cell proliferation.
MCAF1 colocalizes with SETDB1 in PML bodies (data not shown), but not with H3K9me3 in IMR90 cells (Figure 1). Several recent reports demonstrate the PML body localization of SETDB1 in ES cells and in early embryos [27,28]. Our preliminary data suggest that SETDB1 knockdown induces premature senescence. Conversely, SETDB1 is an oncogene whose overexpression in zebra fish abrogates the BRAF(V600E)-induced senescence [26]. Therefore, SETDB1 protein level is also correlated with cell proliferation and senescence in a similar manner with MCAF1. It remains to be elucidated whether the function of the MCAF1/SETDB1 complex in PML bodies is separable from that in heterochromatin in cancer cells. A recent study indicated that the global pattern of H3K9me3 unchanges upon SAHF formation during oncogene-induced senescence, but 3D repositioning of H3K9me3 is involved [29]. In addition, MCAF1 is not required to maintain the H3K9me3 level within SAHF structure (Figure S4). Therefore, MCAF1 and SETDB1-mediated H3K9 methylation is not likely to play major roles during the senescence program.
PML protein plays important roles in the senescence pathway through the p53 signaling, and overexpression of PML induces premature senescence [30,31]. The histone chaperon HIRA accumulates in PML bodies in senescent cells similarly to MCAF1, whereas HP1 localizes to PML bodies at earlier stages of senescence before entering SAHF [32]. How dynamic relocalization of the proteins contributes to the senescence remains largely unknown. As both knockdown and PML body recruitment of MCAF1 are connected with the same senescent phenotypes, sequestration of MCAF1 to PML bodies may be essential to inhibit MCAF1 function to activate transcription of cell cycle and histone genes during the senescence pathway (Figure 5D). SUMO proteins seem to play important roles in this process. Overexpression of SUMO or the SUMO E3 ligase PIA, Sy, or knockdown of the SUMO isopeptidase SENP1 induced senescent-like phenotypes [19,33,34]. Our data show that SUMO2/3 appear to be required for the accumulation of MCAF1 in PML bodies. In cancer cells, MCAF1 is recruited to heterochromatin via the SIM through binding to SUMOylated MBD1 [11]. In senescent cells, there would be some candidates including PML protein itself, which are SUMOylated and recruit MCAF1 to the bodies.
To summarize, our data show that MCAF1 regulates expression of cell cycle and histone genes to maintain cell proliferation, and its inhibition or sequestration to PML bodies are connected with cellular senescence. Given that MCAF1 is overexpressed in various cancers, manipulation of MCAF1 activity or its localization would be a useful tool for anti-cancer therapy.
Supporting Information
Figure S1. MCAF1 localizes to PML bodies in normal cells, but not in cancer cells.
(A) Immunofluorescence analysis of MCAF1 and a heterochromatin marker H3K9me3 in the cancer cell lines HeLa and MCF7. (B) Immunofluorescence of MCAF1 and PML in the normal mammary epithelial cell line HMEC. (C) IMR90 cells were treated with siRNA against MCAF1 for 48 hr and analyzed by immunofluorescence with MCAF1 and PML antibodies.
https://doi.org/10.1371/journal.pone.0068478.s001
(PDF)
Figure S2. Identification of cell cycle genes as MCAF1 targets by microarray analysis.
(A) Gene set enrichment analysis was performed to identify gene sets which were downregulated in MCAF1 knockdown cells compared to control cells. A list of top 20 gene sets is shown. Majority of the gene sets downregulated by MCAF1 knockdown are related to the cell cycle process. (B) Representative results of GSEA of downregulated genes in MCAF1 knockdown cells.
https://doi.org/10.1371/journal.pone.0068478.s002
(PDF)
Figure S3. The cdk inhibitors p16 and p21 are upregulated in MCAF1 knockdown cells.
RT-qPCR analysis of p16 and p21 in control and MCAF1 knockdown cells at 2 days after siRNA treatment.
https://doi.org/10.1371/journal.pone.0068478.s003
(PDF)
Figure S4. SAHF in MCAF1 knockdown cells are enriched for H3K9me3.
Immunofluorescence analysis of MCAF1 and H3K9me3 in control and SAHF-positive MCAF1 knockdown cells.
https://doi.org/10.1371/journal.pone.0068478.s004
(PDF)
Figure S5. The core histone and H1 genes are downregulated in MCAF1 knockdown cells.
(A) RT-qPCR was performed to analyze expression of histone genes in control and MCAF1 knockdown cells at 48 hr after siRNA treatment. (B) RT-qPCR analysis of the variant histone genes H3.3A and macroH2A at 48 hr after siRNA treatment.
https://doi.org/10.1371/journal.pone.0068478.s005
(PDF)
Figure S6. MCAF1 accumulates in PML body in Ras-induced senescent cells.
Line-scan histograms of MCAF1 (green), PML (red), and DAPI (blue) in control (left) and Ras-induced senescent (right) cells. Note that the signal intensity of MCAF1 within PML body in the Ras-induced senescent cells is higher than that in control cells.
https://doi.org/10.1371/journal.pone.0068478.s006
(PDF)
Figure S7. MCAF1 is accumulated in PML bodies in replicatively senescent cells.
Old IMR90 cells which display SAHF were immunostained with antibodies against MCAF1 and PML.
https://doi.org/10.1371/journal.pone.0068478.s007
(PDF)
Figure S8. SUMO2/3 are accumulated in senescent cells.
(A) Immunofluorescence of SUMO2/3 and PML at 0 and 6 days after ER: Ras induction. (B) Western blot analysis to confirm the expression of monomeric EGFP-tagged wild type and the D968A mutant of MCAF1 in IMR90 cells.
https://doi.org/10.1371/journal.pone.0068478.s008
(PDF)
Table S1. A list of primers used in this study.
https://doi.org/10.1371/journal.pone.0068478.s009
(DOC)
Acknowledgments
We would like to thank Drs. H. Kimura (Osaka University) for antibody against H3K9me3, M. Narita (University of Cambridge) for ER: Ras fibroblasts, and our laboratory members for discussions and technical supports.
Author Contributions
Conceived and designed the experiments: N. Sasai MN. Performed the experiments: N. Sasai MN. Analyzed the data: N. Sasai MN. Contributed reagents/materials/analysis tools: N. Saitoh HS. Wrote the manuscript: N. Sasai MN.
References
- 1. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS (2010) The essence of senescence. Genes Dev 24: 2463-2479. doi:https://doi.org/10.1101/gad.1971610. PubMed: 21078816.
- 2. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724. doi:https://doi.org/10.1038/nature03890. PubMed: 16079850.
- 3. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH et al. (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665. doi:https://doi.org/10.1038/nature03841. PubMed: 16079837.
- 4. Narita M, Nũnez S, Heard E, Lin AW, Hearn SA et al. (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716. doi:https://doi.org/10.1016/S0092-8674(03)00401-X. PubMed: 12809602.
- 5. Rai TS, Adams PD (2012) Lessons from senescence: Chromatin maintenance in non-proliferating cells. Biochim Biophys Acta 1819: 322-331. doi:https://doi.org/10.1016/j.bbagrm.2011.07.014. PubMed: 21839870.
- 6. De Graeve F, Bahr A, Chatton B, Kedinger C (2000) A murine ATFa-associated factor with transcriptional repressing activity. Oncogene 19: 1807-1819. doi:https://doi.org/10.1038/sj.onc.1203492. PubMed: 10777215.
- 7. Liu L, Ishihara K, Ichimura T, Fujita N, Hino S et al. (2009) MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity. J Biol Chem 284: 5165-5174. PubMed: 19106100.
- 8. Ichimura T, Watanabe S, Sakamoto Y, Aoto T, Fujita N et al. (2005) Transcriptional repression and heterochromatin formation by MBD1 and MCAF/AM family proteins. J Biol Chem 280: 13928-13935. doi:https://doi.org/10.1074/jbc.M413654200. PubMed: 15691849.
- 9. Wang H, An W, Cao R, Xia L, Erdjument-Bromage H et al. (2003) mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol Cell 12: 475-487. doi:https://doi.org/10.1016/j.molcel.2003.08.007. PubMed: 14536086.
- 10. Fujita N, Watanabe S, Ichimura T, Ohkuma Y, Chiba T et al. (2003) MCAF mediates MBD1-dependent transcriptional repression. Mol Cell Biol 23: 2834-2843. doi:https://doi.org/10.1128/MCB.23.8.2834-2843.2003. PubMed: 12665582.
- 11. Uchimura Y, Ichimura T, Uwada J, Tachibana T, Sugahara S et al. (2006) Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation. J Biol Chem 281: 23180-23190. doi:https://doi.org/10.1074/jbc.M602280200. PubMed: 16757475.
- 12. Sekiyama N, Ikegami T, Yamane T, Ikeguchi M, Uchimura Y et al. (2008) Structure of the small ubiquitin-like modifier (SUMO)-interacting motif of MBD1-containing chromatin-associated factor 1 bound to SUMO-3. J Biol Chem 283: 35966-35975. doi:https://doi.org/10.1074/jbc.M802528200. PubMed: 18842587.
- 13. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M et al. (2009) Autophagy mediates the mitotic senescence transition. Genes Dev 23: 798-803. doi:https://doi.org/10.1101/gad.519709. PubMed: 19279323.
- 14. Hayashi-Takanaka Y, Yamagata K, Wakayama T, Stasevich TJ, Kainuma T et al. (2011) Tracking epigenetic histone modifications in single cells using Fab-based live endogenous modification labeling. Nucleic Acids Res 39: 6475-6488. doi:https://doi.org/10.1093/nar/gkr343. PubMed: 21576221.
- 15. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550. doi:https://doi.org/10.1073/pnas.0506580102. PubMed: 16199517.
- 16. Bernardi R, Pandolfi PP (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8: 1006-1016. doi:https://doi.org/10.1038/nrm2277. PubMed: 17928811.
- 17. McConnell BB, Starborg M, Brookes S, Peters G (1998) Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol 8: 351-354. doi:https://doi.org/10.1016/S0960-9822(98)70137-X. PubMed: 9512419.
- 18. Sporn JC, Kustatscher G, Hothorn T, Collado M, Serrano M et al. (2009) Histone macroH2A isoforms predict the risk of lung cancer recurrence. Oncogene 28: 3423-3428. doi:https://doi.org/10.1038/onc.2009.26. PubMed: 19648962.
- 19. Yates KE, Korbel GA, Shtutman M, Roninson IB, DiMaio D (2008) Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts. Aging Cell 7: 609-621. doi:https://doi.org/10.1111/j.1474-9726.2008.00411.x. PubMed: 18616636.
- 20. O’Sullivan RJ, Kubicek S, Schreiber SL, Karlseder J (2010) Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat Struct Mol Biol 17: 1218-1225. doi:https://doi.org/10.1038/nsmb.1897. PubMed: 20890289.
- 21. Funayama R, Saito M, Tanobe H, Ishikawa F (2006) Loss of linker histone H1 in cellular senescence. J Cell Biol 175: 869-880. doi:https://doi.org/10.1083/jcb.200604005. PubMed: 17158953.
- 22. Feser J, Truong D, Das C, Carson JJ, Kieft J et al. (2010) Elevated histone expression promotes life span extension. Mol Cell 39: 724-735. doi:https://doi.org/10.1016/j.molcel.2010.08.015. PubMed: 20832724.
- 23. Sancho M, Diani E, Beato M, Jordan A (2008) Depletion of human histone H1 variants uncovers specific roles in gene expression and cell growth. PLOS Genet 4: e1000227. PubMed: 18927631.
- 24. Maehara K, Takahashi K, Saitoh S (2010) CENP-A reduction induces a p53-dependent cellular senescence response to protect cells from executing defective mitoses. Mol Cell Biol 30: 2090-2104. doi:https://doi.org/10.1128/MCB.01318-09. PubMed: 20160010.
- 25. Gévry N, Chan HM, Laflamme L, Livingston DM, Gaudreau L (2007) p21 transcription is regulated by differential localization of histone H2A.Z. Genes Dev 21: 1869-1881. doi:https://doi.org/10.1101/gad.1545707. PubMed: 17671089.
- 26. Ceol CJ, Houvras Y, Jane-Valbuena J, Bilodeau S, Orlando DA et al. (2011) The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 471: 513-517. doi:https://doi.org/10.1038/nature09806. PubMed: 21430779.
- 27. Yeap LS, Hayashi K, Surani MA (2009) ERG-associated protein with SET domain (ESET)-Oct4 interaction regulates pluripotency and represses the trophectoderm lineage. Epigenetics Chromatin 2: 12. doi:https://doi.org/10.1186/1756-8935-2-12. PubMed: 19811652.
- 28. Cho S, Park JS, Kang YK (2011) Dual functions of histone-lysine N-methyltransferase Setdb1 protein at promyelocytic leukemia-nuclear body (PML-NB): maintaining PML-NB structure and regulating the expression of its associated genes. J Biol Chem 286: 41115-41124. doi:https://doi.org/10.1074/jbc.M111.248534. PubMed: 21921037.
- 29. Chandra T, Kirschner K, Thuret JY, Pope BD, Ryba T et al. (2012) Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. Mol Cell 47: 203-214. doi:https://doi.org/10.1016/j.molcel.2012.06.010. PubMed: 22795131.
- 30. Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C et al. (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 14: 2015-2027. PubMed: 10950866.
- 31. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M et al. (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207-210. doi:https://doi.org/10.1038/35018127. PubMed: 10910364.
- 32. Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W et al. (2005) Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell 8: 19-30. doi:https://doi.org/10.1016/j.devcel.2004.10.019. PubMed: 15621527.
- 33. Li T, Santockyte R, Shen RF, Tekle E, Wang G et al. (2006) Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways. J Biol Chem 281: 36221-36227. doi:https://doi.org/10.1074/jbc.M608236200. PubMed: 17012228.
- 34. Bischof O, Schwamborn K, Martin N, Werner A, Sustmann C et al. (2006) The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell 22: 783-794.